2 not yet recruiting, 1 completed, 1 terminated. 4 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Not yet recruiting 2, Completed 1, Terminated 1 |
| Phase 3 | 2 | Not yet recruiting 1, Terminated 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Epicentre: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Vaccines Against Bundibugyo Virus Disease in Contacts of Cases in the Democratic Republic of the Congo Candidate BDBV vaccine, Active comparator - Ebola Hemorrhagic Fever, Bundibugyo Virus Disease | Phase 2 / Phase 3 | Not yet recruiting | Jean-Pierre Van geertruyden | 3620 | 2026-10-20 | 2026-10-05 |
| Solidarity/Tokomeza Ebola Trial CAd3, ChAdox1, rVSV-SUDV - Sudan Ebola Virus Vaccines | Phase 1 / Phase 2 | Not yet recruiting | Makerere University | 2121 | 2023-07-01 | 2023-06-18 |
| Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children inhaled nitric oxide, Placebo - Malaria, Cerebral | Phase 2 | Completed | Epicentre | 92 | 2011-09-01 | 2016-03-02 |
| Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda Eflornithine plus Nifurtimox combination therapy - Trypanosomiasis, African | Phase 2 / Phase 3 | Terminated | Epicentre | 31 | 2002-10-01 | 2007-06-21 |
Hemorrhagic Fever, Ebola (1) · Hemorrhagic Fevers, Viral (1) · Malaria (1) · Malaria, Cerebral (1) · Trypanosomiasis, African (1)
Air (1) · Eflornithine (1) · Endothelium-Dependent Relaxing Factors (1) · Nitric Oxide (1) · Nitrogen (1)
Uganda (2) · Democratic Republic of the Congo (1)
Gerardo Priotto, MD MPH (1) · Juliet Mwanga-Amumpaire, Dr (1) · Patrice Piola, MD MSc (1)